Subject Terms: "Subtype" - OpacWWW

Go to position: 1.

Title:: Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
Authors:: Fossum E; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway. .
Rohringer A; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Aune T; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Rydland KM; Division of Infection Control, Department of Vaccines, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Bragstad K; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Hungnes O; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.; Show more
Source:: Virology journal [Virol J] 2024 Mar 06; Vol. 21 (1), pp. 57. Date of Electronic Publication: 2024 Mar 06.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Child ; Humans ; Cross-Sectional Studies ; Antigenic Drift and Shift ; Influenza A Virus, H3N2 Subtype ; Pandemics

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 2.

Title:: Analysis of data from two influenza surveillance hospitals in Zhejiang province, China, for the period 2018-2022.
Authors:: Wang Y; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Liu Y; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Liu G; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Sun X; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Zhang Z; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Shen J; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.; Show more
Source:: PloS one [PLoS One] 2024 Feb 28; Vol. 19 (2), pp. e0299488. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Nucleic Acids*
Child ; Humans ; Influenza A Virus, H3N2 Subtype ; Pandemics ; China/epidemiology ; Seasons ; Hospitals ; Sentinel Surveillance

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 3.

Title:: Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Authors:: Rose AMC; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Bossuyt N; Sciensano, Brussels, Belgium.
Cauchi JP; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Petrović G; Croatian Institute of Public Health, Zagreb, Croatia.
Loghin II; St Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Buda S; Robert Koch Institute, Berlin, Germany.
Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Oroszi B; Semmelweis University, Budapest, Hungary.
Howard J; Epiconcept, Paris, France.
Echeverria A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Andreu C; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Mérida, Spain.
Barbezange C; Sciensano, Brussels, Belgium.
Džiugytė A; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
Popescu CP; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Majauskaite F; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Tolksdorf K; Robert Koch Institute, Berlin, Germany.
Gomez V; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Horváth JK; Semmelweis University, Budapest, Hungary.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
García M; Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Demuyser T; Department of Microbiology and Infection control, UZ Brussel, Brussels, Belgium.
Borg ML; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Tabain I; Croatian Institute of Public Health, Zagreb, Croatia.
Lazar M; 'Cantacuzino' National Military-Medical Institute for Research and Development, Bucharest, Romania.
Kubiliute I; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Dürrwald R; Robert Koch Institute, Berlin, Germany.
Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Kristóf K; Semmelweis University, Budapest, Hungary.
Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Kissling E; Epiconcept, Paris, France.; Show more
Corporate Authors:: VEBIS SARI VE network team
Belgium SARI Surveillance Network (BelsariNet)
Source:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13255.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Pneumonia*
Adult ; Humans ; Seasons ; Influenza A Virus, H3N2 Subtype/genetics ; Case-Control Studies ; Vaccine Efficacy ; Europe/epidemiology ; Hospitalization ; Hospitals ; Vaccination

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 4.

Title:: Genomic Analysis of Influenza A and B Viruses Carrying Baloxavir Resistance-Associated Substitutions Serially Passaged in Human Epithelial Cells.
Authors:: Hickerson BT; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.
Huang BK; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.
Petrovskaya SN; Division of Biotechnology Review and Research III, Food and Drug Administration, Silver Spring, MD 20993, USA.
Ilyushina NA; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.; Show more
Source:: Viruses [Viruses] 2023 Dec 16; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 16.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*
Herpesvirus 1, Cercopithecine*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A Virus, H1N1 Subtype*/metabolism
Thiepins*/pharmacology
Humans ; Oxazines/pharmacology ; Pyridines/pharmacology ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/metabolism ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Epithelial Cells/metabolism ; Genomics ; Viral Proteins/genetics ; Nucleotidyltransferases

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 5.

Title:: A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation.
Authors:: Zhang J; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Liu C; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; Suzhou Research Institute of Shandong University, Suzhou, Jiangsu, P.R. China.
Jia R; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Zhang X; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Zhang J; Institute of Medical Sciences, The Second Hospital, Shandong University, Jinan, Shandong, P.R. China.
Bertagnin C; Department of Molecular Medicine, University of Padova, Padova, Italy.
Bonomini A; Department of Molecular Medicine, University of Padova, Padova, Italy.
Guizzo L; Department of Molecular Medicine, University of Padova, Padova, Italy.
Jiang Y; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Jia H; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Jia S; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Ma X; Institute of Poultry Science, Shandong Academy of Agricultural Sciences, Jinan, Shandong, P.R. China.
Loregian A; Department of Molecular Medicine, University of Padova, Padova, Italy.
Huang B; Institute of Poultry Science, Shandong Academy of Agricultural Sciences, Jinan, Shandong, P.R. China.
Zhan P; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, PR China.
Liu X; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, PR China.; Show more
Source:: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2277135. Date of Electronic Publication: 2023 Nov 13.
Publication Type:: Journal Article
MeSH Terms:: Influenza A Virus, H5N1 Subtype*/metabolism
Influenza A Virus, H1N1 Subtype*
Oseltamivir/pharmacology ; Oseltamivir/chemistry ; Neuraminidase ; Molecular Docking Simulation ; Influenza A Virus, H3N2 Subtype/metabolism ; Glycoside Hydrolases

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 6.

Title:: A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
Authors:: Nittayananta W; Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand. .
Lerdsamran H; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
Chutiwitoonchai N; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand.
Promsong A; Faculty of Medicine, Princess of Naradhiwas University, Narathiwat, Thailand.
Srichana T; Drug Delivery System Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand.; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Netsomboon K; Faculty of Pharmacy, Thammasat University, Pathum Thani, Thailand.
Prasertsopon J; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
Kerdto J; Thammasat Hospital, Thammasat University, Pathum Thani, Thailand.; Show more
Source:: Virology journal [Virol J] 2024 Jan 23; Vol. 21 (1), pp. 26. Date of Electronic Publication: 2024 Jan 23.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*
Curcumin*
Influenza A Virus, H1N1 Subtype*
COVID-19*
Orthomyxoviridae Infections*
Animals ; Dogs ; Humans ; SARS-CoV-2 ; Immunity, Mucosal ; Influenza A Virus, H3N2 Subtype ; Madin Darby Canine Kidney Cells ; Antiviral Agents

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 7.

Title:: Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Authors:: Maurel M; Epiconcept Paris France.
Pozo F; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Pérez-Gimeno G; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Buda S; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Sève N; Sorbonne Université INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136) Paris France.
Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Hooiveld M; Nivel Utrecht the Netherlands.
Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Domegan L; HSE-Health Protection Surveillance Centre Dublin Ireland.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Ilić M; Croatian Institute of Public Health Zagreb Croatia.
Carnahan AS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Mihai ME; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Martínez A; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública de Catalunya Barcelona Spain.
Goerlitz L; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Paris France.
Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Dijkstra F; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Bennett C; National Virus Reference Laboratory University College Dublin Dublin Ireland.
Trobajo-Sanmartín C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Mlinarić I; Croatian Institute of Public Health Zagreb Croatia.
Latorre-Margalef N; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Ivanciuc A; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Lopez A; Subdirección General de Epidemiologia y Vigilancia de la Salud Valencia Spain.
Dürrwald R; National Reference Centre for Influenza Robert Koch Institute Berlin Germany.
Falchi A; Laboratoire de Virologie Université de Corse-Inserm Corte France.
Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Meijer A; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Melo A; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
O'Donnell J; HSE-Health Protection Surveillance Centre Dublin Ireland.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Vučina VV; Croatian Institute of Public Health Zagreb Croatia.
Hagey TS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Kaczmarek M; European Centre for Disease Prevention and Control Stockholm Sweden.
Bacci S; European Centre for Disease Prevention and Control Stockholm Sweden.
Kissling E; Epiconcept Paris France.; Show more
Corporate Authors:: VEBIS study team
Source:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 10; Vol. 18 (1), pp. e13243. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).
Publication Type:: Multicenter Study; Journal Article
MeSH Terms:: Influenza A virus*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Child ; Humans ; Europe/epidemiology ; Influenza A Virus, H3N2 Subtype/genetics ; Primary Health Care ; Vaccine Efficacy ; Infant, Newborn ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Middle Aged

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 8.

Title:: Persistent predominance of the Victoria lineage of influenza B virus during COVID-19 epidemic in Nanchang, China.
Authors:: Zhou X; Jiangxi University of Chinese Medicine Nanchang China.; Nanchang Center for Disease Control and Prevention Nanchang China.
Lin Z; Jiangxi University of Chinese Medicine Nanchang China.
Tu J; Nanchang Center for Disease Control and Prevention Nanchang China.
Zhu C; Third Hospital of Nanchang Nanchang China.
Li H; Nanchang Center for Disease Control and Prevention Nanchang China.; Show more
Source:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Dec 10; Vol. 17 (12), pp. e13226. Date of Electronic Publication: 2023 Dec 10 (Print Publication: 2023).
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Humans ; Influenza B virus/genetics ; Influenza A Virus, H3N2 Subtype ; Pandemics ; China/epidemiology

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 9.

Title:: Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase.
Authors:: Lőrincz EB; Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.; Doctoral School of Pharmaceutical Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
Herczeg M; Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
Houser J; National Centre for Biomolecular Research, Masaryk University, 611 37 Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Rievajová M; Department of Biochemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic.
Kuki Á; Department of Applied Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
Malinovská L; National Centre for Biomolecular Research, Masaryk University, 611 37 Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Naesens L; Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium.
Wimmerová M; National Centre for Biomolecular Research, Masaryk University, 611 37 Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.; Department of Biochemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic.
Borbás A; Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.; National Laboratory of Virology, University of Pécs, H-7624 Pécs, Hungary.; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, H-4032 Debrecen, Hungary.
Herczegh P; Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
Bereczki I; Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.; National Laboratory of Virology, University of Pécs, H-7624 Pécs, Hungary.; Show more
Source:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 08; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 08.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/drug therapy
Influenza A Virus, H1N1 Subtype*
Humans ; N-Acetylneuraminic Acid/pharmacology ; N-Acetylneuraminic Acid/metabolism ; Hemagglutinins/pharmacology ; Neuraminidase/metabolism ; Influenza A Virus, H3N2 Subtype ; Neuraminic Acids ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 10.

Title:: Development and Validation of a Panel of One-Step Four-Plex qPCR/RT-qPCR Assays for Simultaneous Detection of SARS-CoV-2 and Other Pathogens Associated with Canine Infectious Respiratory Disease Complex.
Authors:: Thieulent CJ; Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Carossino M; Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Peak L; Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Strother K; Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Wolfson W; Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Balasuriya UBR; Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.; Show more
Source:: Viruses [Viruses] 2023 Sep 05; Vol. 15 (9). Date of Electronic Publication: 2023 Sep 05.
Publication Type:: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Coinfection*/diagnosis
Coinfection*/veterinary
Influenza A Virus, H1N1 Subtype*
Influenza A Virus, H3N8 Subtype*
COVID-19*/diagnosis
COVID-19*/veterinary
Respiratory Tract Infections*/diagnosis
Respiratory Tract Infections*/veterinary
Canidae*
Dogs ; Animals ; SARS-CoV-2/genetics ; Influenza A Virus, H3N2 Subtype

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 11.

Title:: Epidemiology of Influenza-like Illness and Respiratory Viral Etiology in Adult Patients in Taiyuan City, Shanxi Province, China between 2018 and 2019.
Authors:: Jia Z; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Xue P; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Gao R; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Wang R; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Zhao L; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Zuo Z; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Gao L; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Han R; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Yao H; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.
Guo J; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Xu J; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.
Zhu Z; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Wang J; School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030001, China.; Taiyuan Center for Disease Control and Prevention, No. 22, Huazhang West Street, Xiaodian District, Taiyuan 030032, China.; Show more
Source:: Viruses [Viruses] 2023 Oct 30; Vol. 15 (11). Date of Electronic Publication: 2023 Oct 30.
Publication Type:: Journal Article
MeSH Terms:: Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Virus Diseases*/epidemiology
Adult ; Humans ; China/epidemiology ; Influenza A Virus, H3N2 Subtype

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 12.

Title:: No association between inactivated influenza vaccination and influenza viral load at diagnosis among young Japanese children: An observational study of the 2013/2014 through 2017/2018 influenza seasons.
Authors:: Mukai E; Department of Public Health, Osaka City University Graduate School of Medicine, Osaka, Japan.
Fukushima W; Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.; Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Morikawa S; Department of Virology, Osaka Institute of Public Health, Osaka, Japan.
Nakata K; Department of Virology, Osaka Institute of Public Health, Osaka, Japan.
Hiroi S; Department of Virology, Osaka Institute of Public Health, Osaka, Japan.
Fujioka M; Fujioka Pediatric Clinic, Tondabayashi, Japan.
Matsushita T; Matsushita Kids' Clinic, Kadoma, Japan.
Kubota M; Kubota Children's Clinic, Osaka, Japan.
Yagi Y; Yagi Pediatric Clinic, Yao, Japan.
Takechi T; Takechi Clinic for Pediatrics and Internal Medicine, Osaka, Japan.
Takasaki Y; Takasaki Pediatric Clinic, Fukuoka, Japan.
Shindo S; Shindo Children's Clinic, Fukuoka, Japan.
Yamashita Y; Yamashita Pediatric Clinic, Itoshima, Japan.
Yokoyama T; Yokoyama Children's Clinic, Kasuga, Japan.
Kiyomatsu Y; Kiyomatsu Pediatric Clinic, Fukuoka, Japan.
Matsumoto K; Department of Public Health, Osaka City University Graduate School of Medicine, Osaka, Japan.
Maeda A; Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Kondo K; Management Bureau, Osaka Metropolitan University Hospital, Osaka, Japan.
Ito K; Osaka Metropolitan University Graduate School of Nursing, Osaka, Japan.
Kase T; Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.; Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Ohfuji S; Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.; Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Hirota Y; Clinical Epidemiology Research Center SOUSEIKAI Medical Group (Medical Co. LTA), Fukuoka, Japan.; Show more
Source:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Oct; Vol. 17 (10), pp. e13213.
Publication Type:: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza, Human*/diagnosis
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Humans ; Child ; Child, Preschool ; Seasons ; Influenza A Virus, H3N2 Subtype ; East Asian People ; Viral Load ; Vaccination

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 13.

Title:: ACIP updates recommendations for influenza vaccination.
Authors:: Campos-Outcalt D; University of Arizona, Phoenix.; Show more
Source:: The Journal of family practice [J Fam Pract] 2023 Oct; Vol. 72 (8), pp. 340-347.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
Humans ; Infant ; Influenza A Virus, H3N2 Subtype ; Vaccination ; Immunization Schedule

Academic Journal

in the bookshelf

Full Text Details

Go to position: 14.

Title:: Influenza A and B Viruses in Fine Aerosols of Exhaled Breath Samples from Patients in Tropical Singapore.
Authors:: Chow VTK; Infectious Diseases Translational Research Program, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Tay DJW; Infectious Diseases Translational Research Program, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Chen MIC; Research Office, National Centre for Infectious Diseases, Singapore 308442, Singapore.
Tang JW; Department of Respiratory Sciences, University of Leicester, Leicester LE1 7RH, UK.
Milton DK; Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD 20742, USA.
Tham KW; Department of the Built Environment, College of Design and Engineering, National University of Singapore, Singapore 117356, Singapore.; Show more
Source:: Viruses [Viruses] 2023 Sep 30; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 30.
Publication Type:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza, Human*
Herpesvirus 1, Cercopithecine*
Influenza A Virus, H1N1 Subtype*/genetics
Humans ; Animals ; Dogs ; Influenza A Virus, H3N2 Subtype/genetics ; Singapore ; Respiratory Aerosols and Droplets ; RNA, Viral/genetics

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 15.

Title:: Clinical Features and Outcomes of the Association of Co-Infections in Children with Laboratory-Confirmed Influenza during the 2022-2023 Season: A Romanian Perspective.
Authors:: Merișescu MM; 'Matei Balş' National Institute for Infectious Diseases, No. 1, Calistrat Grozovici Street, 2nd District, 021105 Bucharest, Romania.; Faculty of Medicine, University of Medicine and Pharmacy 'Carol Davila', No. 37, Dionisie Lupu Street, 2nd District, 020021 Bucharest, Romania.
Luminos ML; 'Matei Balş' National Institute for Infectious Diseases, No. 1, Calistrat Grozovici Street, 2nd District, 021105 Bucharest, Romania.; Faculty of Medicine, University of Medicine and Pharmacy 'Carol Davila', No. 37, Dionisie Lupu Street, 2nd District, 020021 Bucharest, Romania.
Pavelescu C; Faculty of Medicine, University of Medicine and Pharmacy 'Carol Davila', No. 37, Dionisie Lupu Street, 2nd District, 020021 Bucharest, Romania.
Jugulete G; 'Matei Balş' National Institute for Infectious Diseases, No. 1, Calistrat Grozovici Street, 2nd District, 021105 Bucharest, Romania.; Faculty of Medicine, University of Medicine and Pharmacy 'Carol Davila', No. 37, Dionisie Lupu Street, 2nd District, 020021 Bucharest, Romania.; Show more
Source:: Viruses [Viruses] 2023 Sep 30; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 30.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/complications
Influenza, Human*/epidemiology
Influenza, Human*/drug therapy
Coinfection*/epidemiology
Influenza A Virus, H1N1 Subtype*
Bacterial Infections*
Communicable Diseases*
Female ; Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Romania/epidemiology ; Retrospective Studies ; Seasons ; Influenza A Virus, H3N2 Subtype ; SARS-CoV-2

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 16.

Title:: Impact of non-pharmaceutical interventions during COVID-19 on future influenza trends in Mainland China.
Authors:: Liu X; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Peng Y; Wuhan Centers for Disease Control and Prevention, Wuhan, 430024, Hubei, China.
Chen Z; Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Jiang F; Department of Biostatistics, University of Iowa, Iowa City, IA, 52242, USA.
Ni F; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Tang Z; Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Yang X; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Song C; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Yuan M; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Tao Z; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Xu J; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Wang Y; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Qian Q; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Ewing RM; Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Yin P; Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430014, China. .
Hu Y; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China. .
Wang W; Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China. .
Wang Y; Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK. .; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK. .; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, SO16 6YD, UK. .; Show more
Source:: BMC infectious diseases [BMC Infect Dis] 2023 Sep 27; Vol. 23 (1), pp. 632. Date of Electronic Publication: 2023 Sep 27.
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza A Virus, H1N1 Subtype*
Humans ; Influenza A Virus, H3N2 Subtype ; Pandemics/prevention & control ; Retrospective Studies ; China/epidemiology

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 17.

Title:: Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
Authors:: Fadlyana E; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Child Health, Bandung, Indonesia.
Dhamayanti M; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Child Health, Bandung, Indonesia.
Tarigan R; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Child Health, Bandung, Indonesia.
Prodjosoewojo S; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Internal Medicine, Bandung, Indonesia.
Rahmadi AR; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Internal Medicine, Bandung, Indonesia.
Sari RM; Surveillance and Clinical Trial Division, PT Bio Farma, Bandung, Indonesia.
Rusmil K; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Child Health, Bandung, Indonesia.
Kartasasmita CB; Faculty of Medicine Universitas Padjadjaran/Hasan Sadikin Hospital, Department of Child Health, Bandung, Indonesia.; Show more
Source:: PloS one [PLoS One] 2023 Aug 24; Vol. 18 (8), pp. e0281566. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).
Publication Type:: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
Humans ; Adult ; Child ; Indonesia ; Influenza A Virus, H3N2 Subtype ; Vaccines, Combined

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 18.

Title:: Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.
Authors:: Sominina A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Danilenko D; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Komissarov AB; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Pisareva M; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Fadeev A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Konovalova N; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Eropkin M; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Petrova P; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Zheltukhina A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Musaeva T; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Eder V; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Ivanova A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Komissarova K; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Stolyarov K; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Karpova L; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Smorodintseva E; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Dorosh A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Krivitskaya V; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Kuznetzova E; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Majorova V; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Petrova E; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Boyarintseva A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Ksenafontov A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Shtro A; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Nikolaeva J; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Bakaev M; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
Burtseva E; National Research Center for Epidemiology and Microbiology Named after N.F. Gamaleya, 123098 Moscow, Russia.
Lioznov D; Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.; Department of Infectious Diseases, First Pavlov State Medical University, 197022 Saint Petersburg, Russia.; Show more
Source:: Viruses [Viruses] 2023 Aug 21; Vol. 15 (8). Date of Electronic Publication: 2023 Aug 21.
Publication Type:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*/genetics
COVID-19*
Humans ; Seasons ; Vaccine Efficacy ; Influenza A Virus, H3N2 Subtype/genetics ; Pandemics ; Russia/epidemiology

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 19.

Title:: A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs.
Authors:: Haach V; Laboratório de Virologia, Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600, Porto Alegre, Rio Grande Do Sul, CEP 90035-003, Brazil.
Bastos APA; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil.
Gava D; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil.
da Fonseca FN; Embrapa Sede, Parque Estação Biológica, Brasília, Distrito Federal, CEP 70770-901, Brazil.; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil.
Morés MAZ; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil.
Coldebella A; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil.
Franco AC; Laboratório de Virologia, Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600, Porto Alegre, Rio Grande Do Sul, CEP 90035-003, Brazil.
Schaefer R; Embrapa Suínos e Aves, BR-153, Km 110, Concórdia, Santa Catarina, CEP 89715-899, Brazil. .; Show more
Source:: Virology journal [Virol J] 2023 Aug 16; Vol. 20 (1), pp. 181. Date of Electronic Publication: 2023 Aug 16.
Publication Type:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza Vaccines*
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Influenza A virus*
Humans ; Animals ; Swine ; Vaccines, Combined ; Immunity, Humoral ; CD8-Positive T-Lymphocytes ; Influenza A Virus, H3N2 Subtype ; Virosomes

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 20.

Title:: Inference of age-dependent case-fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands.
Authors:: McDonald SA; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Teirlinck AC; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Hooiveld M; Nivel Utrecht The Netherlands.
van Asten L; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Meijer A; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
de Lange M; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
van Gageldonk-Lafeber AB; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Wallinga J; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.; Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands.; Show more
Source:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jun 19; Vol. 17 (6), pp. e13146. Date of Electronic Publication: 2023 Jun 19 (Print Publication: 2023).
Publication Type:: Journal Article
MeSH Terms:: Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Humans ; Influenza A Virus, H3N2 Subtype ; Seasons ; Netherlands/epidemiology ; Retrospective Studies ; Bayes Theorem ; Prospective Studies

Academic Journal

in the bookshelf

Full Text Full Text Details

Information

You search for a phrase ""Subtype"" according to the criterion: Subject Terms

Data source

Restrict to:

Select databases

Source Type

Subject

Publisher

Publication

Language

Publication Year